Business
-
Only about a month after entering the nasal delivery device market, Bespak has announced a second contract for development of an intranasal device. The company says that “a major global manufacturer of generic medicines” has… Read more . . .
-
The board of directors of contract research organization PPD has approved a $3.9 billion all cash deal which will take the company private after its acquisition by the Carlyle Group and Hellman & Friedman. PPD… Read more . . .
-
As Nycomed officially becomes a wholly owned subsidiary of Takeda Pharmaceutical Company, Takeda has named Frank Morich as the new Nycomed CEO. Morich will also continue in his current position as Executive VP (EVP) of… Read more . . .
-
Graceway Pharmaceuticals, which manufactures the MaxAir Autohaler pirbuterol acetate MDI, one of the last remaining CFC-propelled metered dose inhalers, has agreed to sell all of its assest to Galderma, a ” company focused exclusively on… Read more . . .
-
Marina Biotech (formerly MDRNA/Nastech) is offering intellectual property related to intranasal formulations of rapid-acting insulin and of parathyroid hormone (PTH) for the treatment of osteoporosis for sale through ICAP Patent Brokerage. ICAP has recently handled… Read more . . .
-
MannKind Corporation has announced a proposed offer of senior secured discount notes, due 2017, that would yield approximately $370 million. The company says that it would use the money to complete Phase 3 clinical trials… Read more . . .
-
Novartis has launched its TOBI Podhaler tobramycin dry powder inhaler in the UK. The DPI, for the treatment of P. aeruginosa infections in cystic fibrosis patients. The CF Trust responded to the launch on its… Read more . . .
-
The US Department of Health and Human Services Biomedical Advanced Research and Development Authority (BARDA) has awarded a $4.4 million contract to Texas-based Southwest Research Institute (SwRI), an independent applied research and development organization, for… Read more . . .
-
During its presentation at the 2011 Morgan Stanley Global Healthcare Conference on September 14, Sun Pharma Advanced Research Company (SPARC) provided a detailed report on the development of its Starhaler dry powder inhaler and announced… Read more . . .
-
Just prior to a scheduled hearing to determine sanctions in the Proveris Scientic vs. InnovaSystems case that was scheduled for September 6, 2011, InnovaSystems filed for bankruptcy, indefinitely delaying the hearing. The petition for Chapter… Read more . . .

Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here


